Review Open Access Logo

Insomnia: Recent Advances in Genetic Aspects and Therapies

Maryam Riasat 1
Ali Afzal 2 ORCID logo
Muhammad Babar Khawar 1, *
Syeda Eisha Hamid 2
Ume Habiba 3 ORCID logo
Sara Shahzaman 2 ORCID logo
Nayab Shahid 2
Rimsha Naseem 2
  1. Applied Molecular Biology & Biomedicine Lab, Department of Zoology, University of Narowal, Narowal, Pakistan
  2. Molecular Medicine and Cancer Therapeutics Lab, Department of Zoology, Faculty of Science and Technology, University of Central Punjab, Lahore, Pakistan
  3. Department of Zoology, University of Education, Lahore, Pakistan
Correspondence to: Muhammad Babar Khawar, Applied Molecular Biology & Biomedicine Lab, Department of Zoology, University of Narowal, Narowal, Pakistan. Email: [email protected].
Volume & Issue: Vol. 10 No. 4 (2023) | Page No.: 5630-5637 | DOI: 10.15419/bmrat.v10i4.804
Published: 2023-04-30

Online metrics


Statistics from the website

  • HTML Views: 6190
  • PDF Views: 1592
  • XML Views: 155

Statistics from Dimensions

This article is published with open access by BioMedPress. This article is distributed under the terms of the Creative Commons Attribution License (CC-BY 4.0) which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. 

Abstract

Insomnia has a significant global incidence rate. Previous observational studies, general practitioner surveys, and medical trials suggest that a variety of patient and physician factors are associated with this, including low patient reporting of insomnia, limited healthcare professional training, office-based time constraints, and misconceptions about the seriousness of insomnia, treatment benefits, and the risks associated with hypnotic use. Here, we discuss the recently studied genetic aspects of insomnia pathogenesis and the orexin system and acupuncture as potential therapeutic strategies.

Sorry, we can not display full-text of this article in HTML format for you right now. Please get the article in PDF format instead.

Comments